These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9611401

  • 1. [Genetic factors, Na K ATPase activity and neuropathy in diabetics].
    Vague P, Dufayet D, Lamotte MF, Mouchot C, Raccah D.
    Bull Acad Natl Med; 1997 Dec; 181(9):1811-21; discussion 1821-3. PubMed ID: 9611401
    [Abstract] [Full Text] [Related]

  • 2. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
    Raccah D, Gallice P, Pouget J, Vague P.
    Diabete Metab; 1992 Dec; 18(3):236-41. PubMed ID: 1327887
    [Abstract] [Full Text] [Related]

  • 3. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M.
    Exp Diabesity Res; 2004 Dec; 5(1):37-50. PubMed ID: 15198370
    [Abstract] [Full Text] [Related]

  • 4. Association of diabetic neuropathy with Na/K ATPase gene polymorphism.
    Vague P, Dufayet D, Coste T, Moriscot C, Jannot MF, Raccah D.
    Diabetologia; 1997 May; 40(5):506-11. PubMed ID: 9165217
    [Abstract] [Full Text] [Related]

  • 5. Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients.
    Jannot MF, Raccah D, De La Tour DD, Coste T, Vague P.
    Metabolism; 2002 Mar; 51(3):284-91. PubMed ID: 11887161
    [Abstract] [Full Text] [Related]

  • 6. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
    Umeda F, Noda K, Hashimoto T, Yamashita T, Nawata H.
    Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
    [Abstract] [Full Text] [Related]

  • 7. Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney.
    Raccah D, Lamotte-Jannot MF, Issautier T, Vague P.
    Diabete Metab; 1994 Nov; 20(3):271-4. PubMed ID: 8001715
    [Abstract] [Full Text] [Related]

  • 8. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
    Djemli-Shipkolye A, Gallice P, Coste T, Jannot MF, Tsimaratos M, Raccah D, Vague P.
    Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
    [Abstract] [Full Text] [Related]

  • 9. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
    Konukoglu D, Kemerli GD, Sabuncu T, Hatemi H.
    Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
    [Abstract] [Full Text] [Related]

  • 10. Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters.
    Djemli-Shipkolye A, Coste T, Raccah D, Vague P, Pieroni G, Gerbi A.
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):297-304. PubMed ID: 11355004
    [Abstract] [Full Text] [Related]

  • 11. Differential effect of omega3 PUFA supplementations on Na,K-ATPase and Mg-ATPase activities: possible role of the membrane omega6/omega3 ratio.
    Djemli-Shipkolye A, Raccah D, Pieroni G, Vague P, Coste TC, Gerbi A.
    J Membr Biol; 2003 Jan 01; 191(1):37-47. PubMed ID: 12532275
    [Abstract] [Full Text] [Related]

  • 12. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
    Mimura M, Makino H, Kanatsuka A, Asai T, Yoshida S.
    Horm Metab Res; 1994 Jan 01; 26(1):33-8. PubMed ID: 8150421
    [Abstract] [Full Text] [Related]

  • 13. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
    Shahid SM, Mahboob T.
    Pak J Pharm Sci; 2008 Apr 01; 21(2):172-9. PubMed ID: 18390448
    [Abstract] [Full Text] [Related]

  • 14. Electrolytes and sodium transport mechanism in diabetes mellitus.
    Shahid SM, Rafique R, Mahboob T.
    Pak J Pharm Sci; 2005 Apr 01; 18(2):6-10. PubMed ID: 16431390
    [Abstract] [Full Text] [Related]

  • 15. Impaired rodent vagal nerve sodium-potassium-ATPase activity in streptozotocin diabetes.
    Nowak TV, Castelaz C, Ramaswamy K, Weisbruch JP.
    J Lab Clin Med; 1995 Feb 01; 125(2):182-6. PubMed ID: 7844468
    [Abstract] [Full Text] [Related]

  • 16. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].
    Han LP, Yu DM, Xie Y.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2513-5. PubMed ID: 19080636
    [Abstract] [Full Text] [Related]

  • 17. Decreased Na/K ATPase ouabain binding sites in red blood cells of patients with insulin-dependent diabetes and healthy north African control subjects: relationship with diabetic neuropathy.
    Raccah D, Dadoun F, Coste T, Vague P.
    Horm Metab Res; 1996 Mar 16; 28(3):128-32. PubMed ID: 8926011
    [Abstract] [Full Text] [Related]

  • 18. Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins.
    Rizvi SI, Zaid MA.
    Clin Chim Acta; 2005 Apr 16; 354(1-2):59-67. PubMed ID: 15748600
    [Abstract] [Full Text] [Related]

  • 19. Evidence of time-dependent changes in renal medullary Na,K-ATPase activity and expression in diabetic rats.
    Tsimarato M, Coste TC, Djemli-Shipkolye A, Daniel L, Shipkolye F, Vague P, Raccah D.
    Cell Mol Biol (Noisy-le-grand); 2001 Mar 16; 47(2):239-45. PubMed ID: 11354996
    [Abstract] [Full Text] [Related]

  • 20. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
    Krishnan AV, Lin CS, Kiernan MC.
    Brain; 2008 May 16; 131(Pt 5):1209-16. PubMed ID: 18362098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.